(Q44175267)

30 November 2017

title

Cardiovascular risk factors during estrogen-norethindrone and cholecalciferol treatment (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1332634

14 September 2022

1 reference

McNair P

3

1 reference

30 November 2017

B. Myrup

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1332634

14 September 2022

G. F. Jensen

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1332634

14 September 2022

P. McNair

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1332634

14 September 2022

language of work or name

English

0 references

publication date

1 November 1992

1 reference

30 November 2017

number of pages

4

1 reference

based on heuristic

inferred from page(s)

published in

JAMA Internal Medicine

1 reference

Archives of internal medicine

30 November 2017

152

11

2265–8

November 1992

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1332634

14 September 2022

volume

152

1 reference

30 November 2017

issue

11

1 reference

30 November 2017

page(s)

2265-2268

1 reference

10.1001/ARCHINTE.152.11.2265

30 November 2017

Identifiers

DOI

1 reference

30 November 2017

1 reference